Dr. Rubin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Medical Center Dr
Biddeford, ME 04005Phone+1 336-832-1100- Is this information wrong?
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 1992 - 1995
- University of Calgary Faculty of MedicineClass of 1988
Certifications & Licensure
- NJ State Medical License 1973 - Present
- ME State Medical License 2016 - 2025
- NH State Medical License 2017 - 2025
- IA State Medical License 2023 - 2025
- NC State Medical License 1993 - 2021
- NY State Medical License 2014 - 2016
- WA State Medical License 1993 - 2015
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
- S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Start of enrollment: 2011 Nov 01
- Tesetaxel as First-line Therapy for Metastatic Breast Cancer Start of enrollment: 2010 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Re: Using the 21‐gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):91...Harry D. Bear, Wen Wan, André Robidoux, Peter Rubin, Steven Limentani, Richard L. White, James Granfortuna, Judith O. Hopkins, Dwight Oldham, Angel Rodriguez, Amy P. Sing> ;Journal of Surgical Oncology. 2017 Jul 28
- 65 citationsUsing the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial.Harry D. Bear, Wen Wan, André Robidoux, Peter Rubin, Steven Limentani, Richard L. White, James Granfortuna, Judith O. Hopkins, Dwight Oldham, Angel Rodriguez, Amy P. Sing> ;Journal of Surgical Oncology. 2017 Jun 1
- 2 citationsPhase II study of lapatinib in combination with vinorelbine, as first or second-line therapy in women with HER2 overexpressing metastatic breast cancerHelen K. Chew, Lee S. Schwartzberg, Suprith Badarinath, Peter Rubin, Grace Shumaker, James P. Daugherty, Michelle DeSilvio, Janine M. Mahoney> ;Springerplus. 2014 Feb 22
- Join now to see all
Press Mentions
- Number of Cancer Clinical Trials to Triple in Maine as NCROP Infuses $5.1M into Maine Health Cancer Care Network (MNCCN)October 7th, 2019
Professional Memberships
- Member
- Member
Hospital Affiliations
- Memorial HospitalNorth Conway, New Hampshire
- Maine Veterans Affairs Medical CenterAugusta, Maine
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: